GLP-3 is a synthetic peptide designed to support metabolic regulation, appetite control, and healthy glucose homeostasis. It functions as an analog in the glucagon-like peptide family, influencing insulin secretion, satiety signaling, and energy balance. Preclinical and early clinical research suggests GLP-3 may assist in weight management, improve postprandial glucose responses, and complement broader metabolic optimization strategies.

Clinicians often incorporate GLP-3 into personalized protocols targeting metabolic health, body composition, and lifestyle support. Its mechanism of action provides a targeted, multi-pathway approach to regulating appetite and energy utilization. As with all peptide therapies, GLP-3 administration should be guided by physician oversight, patient-specific evaluation, and adherence to regulatory standards.